653 related articles for article (PubMed ID: 26370129)
21. Production and biomedical applications of virus-like particles derived from polyomaviruses.
Teunissen EA; de Raad M; Mastrobattista E
J Control Release; 2013 Nov; 172(1):305-321. PubMed ID: 23999392
[TBL] [Abstract][Full Text] [Related]
22. Chimeric Virus-Like Particles of Prawn Nodavirus Displaying Hepatitis B Virus Immunodominant Region: Biophysical Properties and Cytokine Response.
Ninyio NN; Ho KL; Yong CY; Chee HY; Hamid M; Ong HK; Mariatulqabtiah AR; Tan WS
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672018
[TBL] [Abstract][Full Text] [Related]
23. Chimeric Virus-like Particles of Universal Antigen Epitopes of Coronavirus and Phage Qβ Coat Protein Trigger the Production of Neutralizing Antibodies.
Guo Y; Guo R; Ma Y; Chang W; Ming S; Yang G; Guo Y
Curr Top Med Chem; 2021 Oct; 21(14):1235-1250. PubMed ID: 34145995
[TBL] [Abstract][Full Text] [Related]
24. Hamster Polyomavirus Research: Past, Present, and Future.
Jandrig B; Krause H; Zimmermann W; Vasiliunaite E; Gedvilaite A; Ulrich RG
Viruses; 2021 May; 13(5):. PubMed ID: 34068409
[TBL] [Abstract][Full Text] [Related]
25. Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
Joe CCD; Chatterjee S; Lovrecz G; Adams TE; Thaysen-Andersen M; Walsh R; Locarnini SA; Smooker P; Netter HJ
Vaccine; 2020 May; 38(22):3892-3901. PubMed ID: 32284273
[TBL] [Abstract][Full Text] [Related]
26. Serological cross-reactions between four polyomaviruses of birds using virus-like particles expressed in yeast.
Zielonka A; Gedvilaite A; Reetz J; Rösler U; Müller H; Johne R
J Gen Virol; 2012 Dec; 93(Pt 12):2658-2667. PubMed ID: 22933666
[TBL] [Abstract][Full Text] [Related]
27. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
Garg H; Sedano M; Plata G; Punke EB; Joshi A
J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of a single-gene mouse-human chimeric antibody against hepatitis B surface antigen.
Bose B; Khanna N; Acharya SK; Sinha S
J Gastroenterol Hepatol; 2006 Sep; 21(9):1439-47. PubMed ID: 16911690
[TBL] [Abstract][Full Text] [Related]
29. Analysis of the epitope and neutralizing capacity of human monoclonal antibodies induced by hepatitis B vaccine.
Tajiri K; Ozawa T; Jin A; Tokimitsu Y; Minemura M; Kishi H; Sugiyama T; Muraguchi A
Antiviral Res; 2010 Jul; 87(1):40-9. PubMed ID: 20412816
[TBL] [Abstract][Full Text] [Related]
30. Development of a vaccine marker technology: display of B cell epitopes on the surface of recombinant polyomavirus-like pentamers and capsoids induces peptide-specific antibodies in piglets after vaccination.
Neugebauer M; Walders B; Brinkman M; Ruehland C; Schumacher T; Bertling WM; Geuther E; Reiser CO; Reichel C; Strich S; Hess J
Biotechnol J; 2006 Dec; 1(12):1435-46. PubMed ID: 17109492
[TBL] [Abstract][Full Text] [Related]
31. Production of recombinant VP1-derived virus-like particles from novel human polyomaviruses in yeast.
Norkiene M; Stonyte J; Ziogiene D; Mazeike E; Sasnauskas K; Gedvilaite A
BMC Biotechnol; 2015 Aug; 15():68. PubMed ID: 26239840
[TBL] [Abstract][Full Text] [Related]
32. Immunogenicity of Leishmania-derived hepatitis B small surface antigen particles exposing highly conserved E2 epitope of hepatitis C virus.
Czarnota A; Tyborowska J; Peszyńska-Sularz G; Gromadzka B; Bieńkowska-Szewczyk K; Grzyb K
Microb Cell Fact; 2016 Apr; 15():62. PubMed ID: 27075377
[TBL] [Abstract][Full Text] [Related]
33. Murine polyomavirus virus-like particles (VLPs) as vectors for gene and immune therapy and vaccines against viral infections and cancer.
Tegerstedt K; Franzén AV; Andreasson K; Joneberg J; Heidari S; Ramqvist T; Dalianis T
Anticancer Res; 2005; 25(4):2601-8. PubMed ID: 16080500
[TBL] [Abstract][Full Text] [Related]
34. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
[TBL] [Abstract][Full Text] [Related]
35. Cellular and humoral immunogenicity of hamster polyomavirus-derived virus-like particles harboring a mucin 1 cytotoxic T-cell epitope.
Dorn DC; Lawatscheck R; Zvirbliene A; Aleksaite E; Pecher G; Sasnauskas K; Ozel M; Raftery M; Schönrich G; Ulrich RG; Gedvilaite A
Viral Immunol; 2008 Mar; 21(1):12-27. PubMed ID: 18355119
[TBL] [Abstract][Full Text] [Related]
36. Toolbox for non-intrusive structural and functional analysis of recombinant VLP based vaccines: a case study with hepatitis B vaccine.
Mulder AM; Carragher B; Towne V; Meng Y; Wang Y; Dieter L; Potter CS; Washabaugh MW; Sitrin RD; Zhao Q
PLoS One; 2012; 7(4):e33235. PubMed ID: 22493667
[TBL] [Abstract][Full Text] [Related]
37. Generation of recombinant virus-like particles of human and non-human polyomaviruses in yeast Saccharomyces cerevisiae.
Sasnauskas K; Bulavaite A; Hale A; Jin L; Knowles WA; Gedvilaite A; Dargeviciūte A; Bartkeviciūte D; Zvirbliene A; Staniulis J; Brown DW; Ulrich R
Intervirology; 2002; 45(4-6):308-17. PubMed ID: 12602348
[TBL] [Abstract][Full Text] [Related]
38. HIV-1 derived peptides fused to HBsAg affect its immunogenicity.
Gonzalez MC; Kostrzak A; Guetard D; Pniewski T; Sala M
Virus Res; 2009 Dec; 146(1-2):107-14. PubMed ID: 19766153
[TBL] [Abstract][Full Text] [Related]
39. The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.
Zvirbliene A; Kucinskaite-Kodze I; Razanskiene A; Petraityte-Burneikiene R; Klempa B; Ulrich RG; Gedvilaite A
Viruses; 2014 Feb; 6(2):640-60. PubMed ID: 24513568
[TBL] [Abstract][Full Text] [Related]
40. Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice.
Dai W; Xiong P; Zhang X; Liu Z; Chen J; Zhou Y; Ye X; Zhang C
Antiviral Res; 2019 Apr; 164():139-146. PubMed ID: 30817941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]